Tamoxifen

Tamoxifen

Tamoxifen, a synthetic molecule developed in 1971, was introduced in 1977 to treat breast cancer as it slowed the growth of estrogen-dependent tumors. (High estrogen levels promote the cell proliferation induced by growth factors of the breast cells.)

Tumour under a microscope

Mammogram image of a breast tumour

Breast cancer is the most frequent form of cancer among womenBreast cancer is the most frequent form of cancer among women

This type of chemotherapy blocks the natural hormones that can stimulate the growth of cancer cells. Megestrol (Megace) is a synthetic derivative of the naturally occurring steroid hormone, progesterone, and functions in a similar manner.

Did you know?

The early diagnosis of breast cancer promotes curability, so the personal monitoring of breasts is crucial to identify the deformations well in time!